The Dependence of the Electrophysiological Effects of Class III Antiarrhythmic Drug Refralon on the Frequency of Myocardium Activation
Crossref DOI link: https://doi.org/10.1007/s10517-023-05756-8
Published Online: 2023-04-11
Published Print: 2023-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abramochkin, D. V.
Pustovit, O. B.
Mironov, N. Yu.
Filatova, T. S.
Kuzmin, V. S.
Text and Data Mining valid from 2023-03-01
Version of Record valid from 2023-03-01
Article History
Received: 19 September 2022
First Online: 11 April 2023